ATLASScribe Therapeutics (SCTX) earnings date: Dec 2, 2026
Scribe Therapeutics (SCTX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Dec 2, 2026. Analysts expect EPS of -$0.42.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SCTX
| Last price | $14.85 (-3.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.1% |
These figures come from the same calibrated model and valuation as the Scribe Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Scribe Therapeutics reports on Dec 2, 2026. One email the day before, with ATLAS’s read on Scribe Therapeutics. You can switch it off at any time.
Alert me before SCTX reportsFree to start. Creating an account takes under a minute.
Notify me when Scribe Therapeutics reports
Track SCTX free Add Scribe Therapeutics to a free ATLAS watchlist and see its next report date in one place.
SCTX earnings at a glance
| Next report (confirmed) | Wed, Dec 2, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.42 |
| Last report | Sep 2, 2026 · Beat |
| Average EPS surprise | +29.6% |
| Sector | Healthcare · Biotechnology |
Scribe Therapeutics earnings history: last 1 reports
Scribe Therapeutics last reported on Sep 2, 2026: EPS of -$2.62 against an estimate of -$3.72 (+29.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 2, 2026 | -$3.72 | -$2.62 | +29.6% | Beat | +6.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SCTX
See the fair value, the probability range and the earnings history of Scribe Therapeutics on its ATLAS page.
Scribe Therapeutics (SCTX) stock analysisPlans from €3.99 a month.
Scribe Therapeutics earnings: frequently asked questions
When does Scribe Therapeutics (SCTX) report earnings?
Scribe Therapeutics is scheduled to report on Wednesday, December 2, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SCTX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.42 per share (USD). Estimates can change before the report.
Did Scribe Therapeutics beat earnings estimates last quarter?
Scribe Therapeutics last reported on Sep 2, 2026: EPS of -$2.62 against an estimate of -$3.72 (+29.6% surprise), a beat.
How much does SCTX usually move in a day?
On a normal trading day the ATLAS model puts SCTX’s one-day range at about ±5.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Dec 2, 2026
Educational information, not investment advice. Disclaimer